Please login to the form below

Not currently logged in
Email:
Password:

Pascale Richetta moves from AbbVie to UCB

She joins the biopharmaceutical company as executive vice president
Pascale Richetta

UCB has appointed Pascale Richetta to lead the global biopharmaceutical company's new bone patient value unit with effect from 1 February.

The unit was created last year with the development of UCB's patient value organisation and is currently led by its chief medical officer and head of the development of medical practices Iris Loew Friedrich.

In her new role Richetta will also serve at UCB as an executive vice president and member of the Belgium-based company's executive committee.

She has over 20 years of commercial and managerial experience in the pharmaceutical industry having worked with both traditional pharmaceuticals and complex biologics.

Richetta most recently served as vice president for Western Europe and Canada for AbbVie.

Prior to this, Richetta held managerial positions at Abbott, GSK, Ipsen and Servier where she was responsible for the international launch of each company's key drugs.

21st January 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Spirit

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

Patient-centricity in improving patient recruitment advertising
This blog looks into the importance of concepts and patient centricity in patient recruitment....
AI and life sciences
AI: the smart money is on the smart thinking
Looking at the three key areas where AI is being applied: drug discovery, clinical decision-making and clinical trials...
Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....

Infographics